Neglected Tropical Diseases: Gates Celebrates Industry Contribution, Chan Concurs 19/04/2017 by Catherine Saez, Intellectual Property Watch 1 Comment Five years after health institutions and actors including pharmaceutical companies endorsed the London Declaration on Neglected Tropical Diseases, meant to support the World Health Organization to control and eradicate 10 specific diseases by 2020, new commitments were announced today (18 April) in Geneva.
Google’s Waymo v. Uber Lawsuit Reflects High-Stakes IP War In Hot Driverless Car Sector 17/04/2017 by Bruce Gain for Intellectual Property Watch 2 Comments Google’s Waymo claims Uber, an app-based taxi service, stole technology for a critical component for driverless cars, as the one of the world’s most-powerful tech titans wages a fierce legal battle to protect its intellectual property in an emerging area of the automotive industry.
Germany Brings Health Issues To G20; First Health Ministers Meeting In May 13/04/2017 by Catherine Saez, Intellectual Property Watch 1 Comment Global health matters are entering into the Group of Twenty (G20) agenda under the German presidency of the group, which started in December 2016. The first-ever G20 Health Ministers’ meeting is scheduled to take place in May, before the regular G20 meeting in July. This week, a professor from the Graduate Institute of Geneva explained how health has become part of the G20 agenda.
The Deepening Debate Over Vaccines And Antimicrobial Resistance Involves IP 12/04/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment With the looming threat of antimicrobial resistance (AMR), there is growing pressure to use vaccines because they obviate the need to prescribe antibiotics in the first place.
Hiring Freeze At USPTO Concerns Industry Groups 11/04/2017 by Intellectual Property Watch 3 Comments Members of the United States innovator business community have delivered a letter to President Trump requesting that the US Patent and Trademark Office be exempt from the federal hiring freeze announced in January.
UPOV This Week Focused On International Cooperation System; Benin Curiously Ratifies Twice 05/04/2017 by Catherine Saez, Intellectual Property Watch 1 Comment The International Union for the Protection of New Varieties of Plants (UPOV) governing body is meeting this week, along with its technical, and consultative committees. On the agenda is a potential international system of cooperation, disputed by civil society. Separately, Benin, a least-developed country, appears to be in the process of ratifying the UPOV convention, raising questions since a regional organisation of which Benin is part already joined UPOV in 2014.
Revocation Of Broadband Rules Ossifying Poor Privacy Practices, Experts Say 05/04/2017 by Monika Ermert for Intellectual Property Watch 1 Comment CHICAGO, Illinois – US President Trump Monday signed the repeal of the Federal Communications Commission (FCC) broadband privacy rules passed by both houses of Congress in March. The decision by Congress and the new administration to smash the FCC broadband privacy rules, data security and security breach notification obligations do not bode well for internet users who want to have a say with regard to their confidentiality, according to a range of tech experts.
Advisory Group Supports Industry Demand For Audit Of WHO Pandemic Flu Framework 05/04/2017 by Catherine Saez, Intellectual Property Watch 2 Comments The World Health Organization has been recommended to provide details on its spending of funds provided to its pandemic influenza framework by the private sector.
Public-Private Coalition’s High-Profile Delinkage Policy For Emerging Vaccines 04/04/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment It’s early February in Tchaourou district, Borgou in Benin, and a pregnant woman is admitted to hospital. Her premature baby is born by caesarean section but she dies a day later on February 12th. It turns out she had Lassa fever, a deadly viral haemorrhagic disease. But that’s only discovered after the baby is discharged from hospital and taken to northern Togo. The newborn also becomes ill and is taken to hospital for treatment.
The Current And Future Scope Of IPR Estoppel 04/04/2017 by Intellectual Property Watch Leave a Comment David I. Berl and Christopher A. Suarez write: The estoppel provision of the America Invents Act, 35 U.S.C. 315(e), was touted originally as a check against patent challengers using inter partes review (“IPR”) proceedings to attack patents serially on the same or similar grounds. That provision precludes an IPR petitioner, or the real party in interest or privy of the petitioner, from asserting invalidity challenges in subsequent IPR, district court, or International Trade Commission (“ITC”) proceedings “on any ground that the petitioner raised or reasonably could have raised during” an IPR that resulted “in a final written decision.” Given the frequency of IPR and associated district court challenges, the scope of the AIA’s estoppel provision, with respect to the parties and arguments it estops, has become and will continue to be a critical and frequently contested issue for litigants.